var data={"title":"Continuous renal replacement therapy solution: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Continuous renal replacement therapy solution: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/348030?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929284\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Duosol;</li>\n      <li>Phoxillum;</li>\n      <li>PrismaSol;</li>\n      <li>PureFlow B</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929287\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Dialysis Solution;</li>\n      <li>\n        Renal Replacement Solution</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929368\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Continuous renal replacement circuit:</b> Pre- or post-hemofilter or hemodiafilter: Volume of solution administered depends upon the patient's clinical condition and fluid, electrolyte, acid-base, and glucose balance.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929367\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span>\n    <p style=\"text-indent:0em;display:inline\">Infants, Children, and Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F28000555\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929369\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929374\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution, Intravenous:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Duosol Bicarb 35 Dialysate K0/Ca3: Bicarbonate 35 mEq/L, chloride 109 mEq/L, glucose 100 mg/dL, magnesium 1 mEq/L, sodium 140 mEq/L, calcium 3 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Duosol Bicarb 35 Dialysate K2/Ca3: Bicarbonate 35 mEq/L, chloride 111 mEq/L, glucose 100 mg/dL, magnesium 1 mEq/L, sodium 140 mEq/L, potassium 2 mEq/L, calcium 3 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Duosol Bicarb 25 Dialysate K2/Ca0: Bicarbonate 25 mEq/L, chloride 115 mEq/L, magnesium 1.5 mEq/L, sodium 136 mEq/L, potassium 2 mEq/L, (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Duosol Bicarb 32 Dialysate K2/Ca0: Bicarbonate 32 mEq/L, chloride 107.5 mEq/L, magnesium 1.5 mEq/L, sodium 136 mEq/L, potassium 2 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Duosol Bicarb 35 Dialysate K4/Ca3: Bicarbonate 35 mEq/L, chloride 113 mEq/L, magnesium 1 mEq/L, sodium 140 mEq/L, potassium 4 mEq/L, calcium 3 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Duosol Bicarb 25 Dialysate K4/Ca0: Bicarbonate 25 mEq/L, chloride 117 mEq/L, magnesium 1.5 mEq/L, sodium 136 mEq/L, potassium 4 mEq/L, magnesium 1.5 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Phoxillum BK4/2.5: Bicarbonate 32 mEq/L, chloride 114.5 mEq/L, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L, phosphate 1 mmol/L, calcium 2.5 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Phoxillum BK4/0: Bicarbonate 22 mEq/L, chloride 122 mEq/L, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L, phosphate 1 mmol/L, calcium 0 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Phoxillum B22K4/0: Bicarbonate 22 mEq/L, chloride 122 mEq/L, magnesium 1.5 mEq/L, phosphate 1 mmol/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Phoxillum BK4/2.5: Bicarbonate 32 mEq/L, calcium 2.5 mEq/L, chloride 114.5 mEq/L, magnesium 1.5 mEq/L, phosphate 1 mmol/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PrismaSol B22GK 2/0: Bicarbonate 22 mEq/L, chloride 118.5 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.5 mEq/L, potassium 2 mEq/L, sodium 140 mEq/L (5000 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PrismaSol B22GK 4/0: Bicarbonate 22 mEq/L, chloride 120.5 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PrismaSol BGK 2/0: Bicarbonate 32 mEq/L, chloride 108 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1 mEq/L, potassium 2 mEq/L, sodium 140 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PrismaSol BGK 4/0/1.2: Bicarbonate 32 mEq/L, chloride 110.2 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.2 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PrismaSol BGK 0/2.5: Bicarbonate 32 mEq/L, calcium 2.5 mEq/L, chloride 109 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.5 mEq/L, sodium 140 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PrismaSol BGK 2/3.5: Bicarbonate 32 mEq/L, calcium 3.5 mEq/L, chloride 111.5 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1 mEq/L, potassium 2 mEq/L, sodium 140 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PrismaSol BGK 4/2.5: Bicarbonate 32 mEq/L, calcium 2.5 mEq/L, chloride 113 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">PrismaSol BK 0/0/1.2: Bicarbonate 32 mEq/L, chloride 106.2 mEq/L, lactate 3 mEq/L, magnesium 1.2 mEq/L, sodium 140 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-400: Bicarbonate 35 mEq/L, chloride 111 mEq/L, glucose 100 mg/dL, magnesium 1 mEq/L, potassium 2 mEq/L, sodium 140 mEq/L, calcium 3 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-401: Bicarbonate 35 mEq/L, chloride 113 mEq/L, glucose 100 mg/dL, magnesium 1 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L, calcium 3 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-402: Bicarbonate 35 mEq/L, chloride 109 mEq/L, glucose 100 mg/dL, magnesium 1 mEq/L, potassium 0 mEq/L, sodium 140 mEq/L, calcium 3 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-403: Bicarbonate 35 mEq/L, chloride 108.5 mEq/L, glucose 100 mg/dL, magnesium 1.5 mEq/L, potassium 2 mEq/L, sodium 140 mEq/L, calcium 0 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-404: Bicarbonate 35 mEq/L, chloride 113 mEq/L, glucose 100 mg/dL, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L, calcium 2.5 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-405: Bicarbonate 35 mEq/L, chloride 110.5 mEq/L, glucose 100 mg/dL, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L, calcium 0 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-453: Bicarbonate 25 mEq/L, chloride 108.5 mEq/L, glucose 100 mg/dL, magnesium 1.5 mEq/L, potassium 2 mEq/L, sodium 130 mEq/L, calcium 0 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-454: Bicarbonate 25 mEq/L, chloride 110.5 mEq/L, glucose 100 mg/dL, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 130 mEq/L, calcium 0 mEq/L (5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pureflow B RFP-456: Bicarbonate 25 mEq/L, chloride 120.5 mEq/L, glucose 100 mg/dL, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L, calcium 0 mEq/L (5000 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50047948\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49507816\" class=\"block dosfc drugH1Div\"><span class=\"drugH1\">Dosage Forms Considerations</span>\n    <p style=\"text-indent:0em;\">Strength presented in the Dosage Forms field represents the final solution after mixing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929370\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Ensure separate compartments are mixed completely prior to use. Administer into the extracorporeal circuit before (pre-dilution) the hemofilter or hemodiafilter; after (post-dilution) the hemofilter or hemodiafilter; or before and after the hemofilter or hemodiafilter.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929288\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Continuous renal replacement circuit:</b> Used as a replacement solution in continuous renal replacement therapy (CRRT) to replace water and to correct electrolyte and acid-base imbalances; in drug poisoning when CRRT is used to remove  dialyzable substances (Phoxillum and PrismaSol only)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5977832\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">High alert medication:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error. </p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929343\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Acid-base imbalance, altered serum glucose, disturbance in fluid balance; electrolyte disturbance (calcium, phosphorus, potassium)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929289\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to any component of the formulation.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929290\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Fluid and electrolyte imbalances: Multiple electrolyte and volume abnormalities may occur (Fall 2010). Monitor hemodynamic status, input/output, potassium, phosphorous, other electrolytes, and acid-base balance throughout the procedure. Abnormalities may be corrected by changing the formulation of replacement solution and/or dialysate, supplementation, or adjusting flow rates appropriately.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Glucose abnormalities: Solutions may increase the risk for hyperglycemia or hypoglycemia depending on the dextrose content of the replacement solution; abnormalities may require initiation of or modification of antidiabetic therapy during treatment. Adjusting solutions or rates of administration may cause changes in dextrose delivery. Monitor blood glucose regularly.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Anticoagulants: Citrate, when used as an anticoagulant, can contribute to the base load and cause hypocalcemia.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form</i></b>\n      <b>\n        <i> specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hydrogen phosphate: Phoxillum replacement solutions contain hydrogen phosphate (a weak acid) and may increase the risk of metabolic acidosis.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Administer only under the direction of a health care provider competent in intensive care treatment, including CRRT. Use only with extracorporeal dialysis equipment appropriate for CRRT.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F28000551\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F28000552\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. Administration to pregnant women with appropriate monitoring would not be expected to cause harm to the fetus.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F28000554\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">These products are excreted in breast milk. Administration to a lactating woman with appropriate monitoring would not be expected to cause harm to the nursing infant.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929372\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Hemodynamic status; fluid, electrolyte and acid-base balance; serum glucose. Concentrations of certain dialyzable drugs may need to be monitored and appropriate therapy implemented to correct for removal during CRRT.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5929363\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Replacement fluids achieve fluid and electrolyte balance by substituting for the ultrafiltrate removed during some forms of CRRT. Replacement solutions may vary in composition and may include a buffer and electrolytes to manage acid-base disorders and electrolyte imbalances.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26116539\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (PrismaSol B22GK 4/0 Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">22-4 mEq/L (5000 mL): $57.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (PrismaSol BGK 0/2.5 Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">32-2.5 mEq/L (5000 mL): $57.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (PrismaSol BGK 2/0 Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">32-2 mEq/L (5000 mL): $57.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (PrismaSol BGK 2/3.5 Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">32-2-3.5 mEq/L (5000 mL): $57.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (PrismaSol BGK 4/0/1.2 Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">32-4-1.2 mEq/L (5000 mL): $57.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (PrismaSol BGK 4/2.5 Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">32-4-2.5 mEq/L (5000 mL): $57.15</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (PrismaSol BK 0/0/1.2 Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">32-1.2 mEq/L (5000 mL): $57.15</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50168874\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Duosol (CZ, DK, EE, HR, LT, LV, PL, PT, SI);</li>\n      <li>Phoxilium (AT, AU, DK, EE, ES, FR, HR, IE, IL, KR, LT, LV, MT, NO, NZ, PL, PT, RO, SI, SK);</li>\n      <li>Prismasol (AT, DK, EE, ES, FR, IE, IL, KR, LT, LV, MT, NO, PL, PT, RO, SA, SK);</li>\n      <li>Prosmasol (SI)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Culley CM, Bernardo JF, Gross PR, et al. Implementing a standardized safety procedure for continuous renal replacement therapy solutions. <i>Am J Health Syst Pharm.</i> 2006;63(8):756-763.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/continuous-renal-replacement-therapy-solution-drug-information/abstract-text/16595818/pubmed\" target=\"_blank\" id=\"16595818\">16595818</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Duosol (renal replacement solution) [prescribing information]. Bethlehem, PA: B. Braun Medical Inc. http://www.bbraunusa.com/products.html?prid=PRID00007061. Accessed January 23, 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Fall P and Szerlip HM. Continuous renal replacement therapy: cause and treatment of electrolyte complications.<i> Semin Dial.</i> 2010;23(6):581-585.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/continuous-renal-replacement-therapy-solution-drug-information/abstract-text/21166876/pubmed\" target=\"_blank\" id=\"21166876\">21166876</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mehta RL. Continuous renal replacement therapy in the critically ill patient. <i>Kidney Int. </i>2005;67(2):781-795.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/continuous-renal-replacement-therapy-solution-drug-information/abstract-text/15673337/pubmed\" target=\"_blank\" id=\"15673337\">15673337</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    NxStage Pureflow B Solutions (renal replacement solution) [prescribing information]. Lawrence, MA: NxStage Medical, Inc; 2017. http://www.nxstage.com/hcp/products/pureflow-b-solution/ Accessed January 20, 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Primasol and Phoxillum (renal replacement solution) [prescribing information]. Daytona Beach, FL: Gambro Renal Products, Inc; June 2017.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 8851 Version 65.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F5929284\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F5929287\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F5929368\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F5929367\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F28000555\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F5929369\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F5929374\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F50047948\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms Considerations\" href=\"#F49507816\" class=\"outlineLink\">Dosage Forms Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F5929370\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F5929288\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F5977832\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F5929343\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F5929289\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F5929290\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F28000551\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F28000552\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F28000554\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F5929372\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F5929363\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F26116539\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F50168874\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/8851|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div>","javascript":null}